Neuromyelitis optica myelin oligodendrocyte glycoprotein antibody-positive (Q41156): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Created a new Item
 
‎Changed label, description and/or aliases in pt-br, en
description / pt-brdescription / pt-br
 
Transtornos do espectro associado ao anticorpo anti-MOG são doenças inflamatórias desmielinizantes do sistema nervoso central com predileção pelo nervo óptico que incluem um subgrupo de pacientes com neurite óptica (NO) bilateral, mielite longitudinal extensa (> 3 segmentos vertebrais) (frequentemente recorrente) e raramente pacientes com apresentação de NMO-like, O fenótipo clínico e imunopatológico está sob investigação ativa.
description / endescription / en
 
MOG antibody associated spectrum disorders are inflammatory demyelinating diseases of the central nervous system with a predilection for optic nerve that include a subgroup of patients with bilateral optic neuritis (ON), longitudinally extensive (> 3 vertebral segments) myelitis (often recurrent) and rarely patients with an NMO like presentation. The clinical and immunopathological phenotype is under active investigation

Revision as of 07:13, 13 August 2026

MOG antibody associated spectrum disorders are inflammatory demyelinating diseases of the central nervous system with a predilection for optic nerve that include a subgroup of patients with bilateral optic neuritis (ON), longitudinally extensive (> 3 vertebral segments) myelitis (often recurrent) and rarely patients with an NMO like presentation. The clinical and immunopathological phenotype is under active investigation
Language Label Description Also known as
default for all languages
8A41.1
    English
    Neuromyelitis optica myelin oligodendrocyte glycoprotein antibody-positive
    MOG antibody associated spectrum disorders are inflammatory demyelinating diseases of the central nervous system with a predilection for optic nerve that include a subgroup of patients with bilateral optic neuritis (ON), longitudinally extensive (> 3 vertebral segments) myelitis (often recurrent) and rarely patients with an NMO like presentation. The clinical and immunopathological phenotype is under active investigation

      Statements